We describe a case of symptomatic primary Cytomegalovirus infection in a HIV-positive pregnant woman on antiretroviral treatment with a CD4 count >200 × 106/l requiring intravenous ganciclovir. No adverse consequences from ganciclovir or evidence of congenital Cytomegalovirus infection were found.
BonalumiSTrapaneseASantamariaA. Cytomegalvirus infection in pregnancy: review of the literature. J Prenat Med2011; 5: 1–8.
2.
JOGC Clinical Practice Guideline. Cytomegalovirus infection in pregnancy. No. 240. April 2010.
3.
Lopo S, Vinagre E, Palminha P, et al. Seroprevalence to cytomegalovirus in the Portuguese population, 2002–2003. Euro Surveill 2011; 16: article 5.
4.
KnowlesSJGrundyKCahillI. Low cytomegalovirus sero-prevalence in Irish pregnant women. Irish Med J2005; 98: 210–212.
5.
BhideAPapageorghiouA. Managing primary CMV infection in pregnancy. BJOG2008; 115: 805–807.
6.
De Paschale M, Agrappi C, Manco MT, et al. Incidence and risk of cytomegalovirus infection during pregnancy in an urban area of Northern Italy. Infect Dis Obstet Gynecol 2009; 2009: article ID 206505, 5 pages.
7.
ColugnatiFStarasSDollardS. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis2007; 7: 71–71.
Rola-PlezczynskiMFrenkelLDFuccilloD. Specific impairment of cell mediated immunity in mothers of infants with congenital infection due to cytomegalovirus. J Infect Dis1977; 135: 386–391.
10.
GherzRCChristiansonWRLinerKM. Cytomegalovirus-specific humoral and cellular immune responses in human pregnancy. J Infect Dis1981; 143: 391–395.
11.
PuliyandaDPSilvermanNSLehmanD. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis2005; 7: 71–74.
12.
PescovitzMD. Absence of teratogenicity of oral ganciclovir used during early pregnancy in a liver transplant recipient. Transplantation1999; 67: 758–759.
